This company has been acquired
Paratek Pharmaceuticals Dividende
Dividende contrôle des critères 0/6
Paratek Pharmaceuticals does not have a record of paying a dividend.
Informations clés
n/a
Rendement du dividende
n/a
Ratio de distribution
Rendement moyen de l'industrie | 2.2% |
Prochaine date de paiement du dividende | n/a |
Date ex-dividende | n/a |
Dividende par action | n/a |
Résultat par action | -US$1.09 |
Prévision de rendement du dividende | n/a |
Mises à jour récentes des dividendes
Pas de mise à jour
Recent updates
Improved Revenues Required Before Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Stock's 77% Jump Looks Justified
Apr 17Paratek Pharmaceuticals: Patience Is Wearing Thin
Aug 24Paratek Pharmaceuticals GAAP EPS of -$0.33 beats by $0.01, revenue of $29.6M beats by $0.42M
Aug 03Paratek Pharmaceuticals: A Deeply Undervalued Antibiotic Company
Jan 03The Play On Paratek Pharmaceuticals
Oct 18Peeking Back In On Paratek Pharmaceuticals
Aug 07Paratek Pharma launches Phase 2b Nuzyra study in nontuberculous mycobacterial
Jun 16Paratek shares rise after FDA approves NUZYRA oral only dosing regimen
Jun 01Paratek Offers Long-Term Value Potential In The Difficult Antibiotic Business
Apr 27Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK): Are Analysts Optimistic?
Mar 01Could The Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Ownership Structure Tell Us Something Useful?
Feb 01Paratek Pharmaceuticals secures $60M non-recourse loan for Hercules debt repayment
Jan 04Paratek Pharmaceuticals: 100%+ Upside As Nuzyra Sales Scale
Dec 01Paratek Pharmaceuticals, Inc. 2020 Q3 - Results - Earnings Call Presentation
Nov 06Stabilité et croissance des paiements
Récupération des données sur les dividendes
Dividende stable: Insufficient data to determine if PRTK's dividends per share have been stable in the past.
Dividende croissant: Insufficient data to determine if PRTK's dividend payments have been increasing.
Rendement des dividendes par rapport au marché
Paratek Pharmaceuticals Rendement des dividendes par rapport au marché |
---|
Segment | Rendement du dividende |
---|---|
Entreprise (PRTK) | n/a |
25% du marché (US) | 1.4% |
25% du marché (US) | 4.4% |
Moyenne du secteur (Pharmaceuticals) | 2.2% |
Analyste prévisionnel (PRTK) (jusqu'à 3 ans) | n/a |
Dividende notable: Unable to evaluate PRTK's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
Dividende élevé: Unable to evaluate PRTK's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Bénéfice distribué aux actionnaires
Couverture des revenus: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Paiement en espèces aux actionnaires
Couverture des flux de trésorerie: Unable to calculate sustainability of dividends as PRTK has not reported any payouts.